Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Penny Stocks

Numinus’ Ongoing Collaboration With Health Canada Spurs Mindspace Clinic Approval In Quebec

By The Dales Report
Today, 3:54 AM
A longstanding commitment of Numinus Wellness Inc. (OTC: NUMIF) to collaborate with Health Canada to help shape protocols for the Special Access Program appears to be paying dividends.

NUMIF

Read More
6 minute read
  • Cannabis
  • Markets
  • Penny Stocks
  • Psychedelics
  • Small Cap

Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies

By Natan Ponieman
Today, 3:54 AM
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022.

ATAI

Read More
1 minute read
  • Biotech
  • Cannabis
  • General
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Numinus Granted Canada’s Special Access Program For Magic Mushrooms To Treat Life-Threatening Conditions

By Fermin Orgambide
Today, 3:54 AM
Numinus Wellness Inc (OTCQB: NUMIF) has been approved to use psilocybin-assisted therapy through Health Canada’s Special Access Program (SAP), marking the first instance in which Numinus will provide this treatment outside of a clinical trial.

NUMIF

Read More
2 minute read
  • Biotech
  • Cannabis
  • General
  • M&A
  • Markets
  • News
  • Psychedelics
  • Small Cap

Novamind And Numinus Prepare For Acquisition, Both Companies Share Info Circulars To Shareholders

By Fermin Orgambide
Today, 3:54 AM
June 8, 2022 marks a turning point for both Numinus (OTCQX: NUMIF) and Novamind (OTCQB: NVMDF).

BNOX

Read More
5 minute read
  • Biotech
  • Cannabis
  • General
  • Markets
  • News
  • Psychedelics

Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward

By Natan Ponieman
Today, 3:54 AM
The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions.

ATAI

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Novamind To Offer Virtual Mental Health Therapy Sessions

By Fermin Orgambide
Today, 3:54 AM
Novamind (OTCQB: NVMDF), which is to be acquired by Numinus Wellness (OTCMKTS: NUMIF), recently announced a collaboration with health coaching platform HealCommunit

NUMIF

Read More
2 minute read
  • M&A
  • Markets
  • Penny Stocks
  • Psychedelics
  • Small Cap

Numinus Wellness Strives To Become Psychedelic Research Hub After Acquisition Of Novamind Inc.

By The Dales Report
Today, 3:54 AM
In a year where M&A activity is expected to ratchet-up in 2022, Numinus Wellness Inc. (OTC: NUMIF) is among the first to take action.

MNMD

Read More
2 minute read
  • Cannabis
  • M&A
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Numinus To Acquire Novamind For $20.74M In Stock

By Vuk Zdinjak
Today, 3:54 AM
Numinus Wellness Inc. (TSX:NUMI)(OTCQX:NUMIF) and Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) have entered into a definitive arrangement agreement pursuant to which…

CSE:NM

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Numinus Administers MDMA To First Volunteer In Clinical Trial Sponsored By MAPS

By Fermin Orgambide
Today, 3:54 AM
Numinus Wellness Inc. (OTCQX:NUMIF), announced that clinical trial MAPPUSX has gotten underway with the enrolling and dosing of the…

NUMIF

Read More
3 minute read
  • Cannabis
  • Entrepreneurship
  • General
  • Markets
  • Movers & Shakers
  • News
  • Penny Stocks

Cannabis Movers & Shakers: TGOD, Numinus Wellness, GTI, Neptune Wellness

By Jelena Martinovic
Today, 3:54 AM
The Green Organic Dutchman Names New CFO The Green Organic Dutchman Holdings Ltd. (CSE:TGOD) (OTC: TGODF) recently tapped Nichola Thompson to oversee the company's finance department.

CSE:GTII

Posts navigation

Previous 1 … 9 10 11 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service